Baum Hedlund has the longest track-record handling SSRI antidepressant litigation, having litigated over 3,000 antidepressant cases in the past 20 years. The firm has many plaintiff attorneys specifically dedicated to litigating the SSRI antidepressant cases.

The firm maintains the highest AV® peer review legal rating and is recognized as a preeminent plaintiff firm that tries or settles serious personal injury and wrongful death lawsuits across the nation.

Focusing a major part of its practice on drug product liability, the firm has been representing victims of defective drugs since the late 1980s. Since 1990 Baum Hedlund has been handling SSRI (selective serotonin reuptake inhibitors) antidepressant cases and served on the Plaintiffs' Steering Committee in the early 1990s in the first SSRI-suicide litigation involving Prozac (the first SSRI approved by the FDA for marketing in the U.S.).

Baum Hedlund exposes and litigates defective pharmaceutical products and has served on plaintiffs' steering committees that manage the complex multi-district litigation arising from pharmaceutical and drug manufacturer negligence.

The firm has filed lawsuits and currently represents families of children from across the United States who have suffered PPHN and heart birth defects due to their mothers' use of antidepressants during pregnancy.

Baum Hedlund has filed Paxil suicide lawsuits across the country involving both children and adults including a nationwide class action involving suicide by youths.

Past efforts by Baum Hedlund have resulted in improvements in drug safety including the most recent FDA black box suicide warning issued on certain antidepressants. The firm’s efforts get innocent victims compensated when duties are neglected or wilfully disregarded. Hundreds of individual clients and thousands of class claimants from every state in the United States and 5 of the 7 continents have been successfully represented by Baum Hedlund.

Baum Hedlund has been on the prevailing side of some of the nation's most highly-publicized cases. Such litigation involves complex evidence and choice of law issues which have been routinely handled by the firm in both state and federal courts. Many of their attorneys have delivered Continuing Legal Education accredited lectures and written articles on the complexities of mass tort litigation. Baum Hedlund is accustomed to handling the simplest and most complex cases: and are here to solve legal problems caused by defective conduct.

In addition to their court activities, Baum Hedlund attorneys are strong public health advocates. They have fought and continue to fight for proper warnings on pharmaceutical drugs. They have testified about the dangers of SSRI antidepressants on several occasions before the Food and Drug Administration. Baum Hedlund attorneys, staff and clients have met with FDA and Department of Health and Human Resources officials, as well as met with members of the U.S. House and Senate regarding the risk of antidepressant induced suicidality.

Our law firm also assisted Congressional Investigators from two separate Committee investigations who later interrogated pharmaceutical executives and FDA officials about their failure to protect the public health related to antidepressants and their association with suicidality.

The firm was established more than 30 years ago and has offices in Los Angeles, Philadelphia, and Washington, D.C. They have represented victims of personal injury and wrongful death for over 25 years and their attorneys have tried well over 200 cases in their careers.

Martindale-Hubbell is the facilitator of a peer review rating process. Ratings reflect the confidential opinions of members of the Bar and the Judiciary.
Martindale-Hubbell Ratings fall into two categories - legal ability and general ethical standards.
AV® Preeminent ™ is a certification mark of Reed Elsevier Properties Inc., used in accordance with the
Martindale-Hubbell certification procedures, standards and policies.

The cases represented on this site or our past performance, verdicts, settlements,
testimonials or endorsements do not constitute a guarantee, warranty,
or prediction regarding the outcome of future cases.